Peters J - Search Results

1

In vitro Approaches to Support Bioequivalence and Substitutability of Generic Proton Pump Inhibitors via Nasogastric Tube Administration.

Ren P, Cui M, Anand O, Xia L, Zhao ZJ, Sun D, Sharp T, Conner DP, Peters J, Jiang W, Stier E, Jiang X. Ren P, et al. Among authors: peters j. AAPS J. 2017 Nov;19(6):1593-1599. doi: 10.1208/s12248-017-0137-x. Epub 2017 Sep 6. AAPS J. 2017. PMID: 28879628

2

International Guidelines for Bioequivalence of Locally Acting Orally Inhaled Drug Products: Similarities and Differences.

Lu D, Lee SL, Lionberger RA, Choi S, Adams W, Caramenico HN, Chowdhury BA, Conner DP, Katial R, Limb S, Peters JR, Yu L, Seymour S, Li BV. Lu D, et al. AAPS J. 2015 May;17(3):546-57. doi: 10.1208/s12248-015-9733-9. Epub 2015 Mar 11. AAPS J. 2015. PMID: 25758352 Free PMC article. Review.

3

Generic drugs--safe, effective, and affordable.

Peters JR, Hixon DR, Conner DP, Davit BM, Catterson DM, Parise CM. Peters JR, et al. Dermatol Ther. 2009 May-Jun;22(3):229-40. doi: 10.1111/j.1529-8019.2009.01236.x. Dermatol Ther. 2009. PMID: 19453347 Review.

4

Drug Information Association Pharmacovigilance and Risk Management Strategies 2017: Overview of the Generic Drug Program and Surveillance.

Chazin HD, Peters JR, Catterson DM, Osterhout JL, Forsyth LM, Lee JE, Kim EK, Feibus KB. Chazin HD, et al. Ther Innov Regul Sci. 2019 Mar;53(2):249-253. doi: 10.1177/2168479018774557. Epub 2018 May 9. Ther Innov Regul Sci. 2019. PMID: 29742934 Free PMC article.

5

Prioritization of Generic Drug Review.

Toufanian M, Peters JR, Uhl K. Toufanian M, et al. JAMA Intern Med. 2017 Jan 1;177(1):140-141. doi: 10.1001/jamainternmed.2016.7811. JAMA Intern Med. 2017. PMID: 28030732 No abstract available.

6

Comparative Risk Assessment of Formulation Changes in Generic Drug Products: A Pharmacology/Toxicology Perspective.

Rayavarapu S, Braithwaite E, Dorsam R, Osterhout J, Furlong LA, Shetty D, Peters JR. Rayavarapu S, et al. Among authors: peters jr. Toxicol Sci. 2015 Jul;146(1):2-10. doi: 10.1093/toxsci/kfv074. Toxicol Sci. 2015. PMID: 26101235 Review.

7

Abbreviated New Drug Applications: Generic Drug User Fee Amendments Act Analysis of Application Quality Metrics.

Woo J, Luan JJ, Li Z, Grosser S, Peters J, Chazin H. Woo J, et al. Among authors: peters j. Ther Innov Regul Sci. 2019 Sep;53(5):696-700. doi: 10.1177/2168479018806192. Epub 2018 Oct 25. Ther Innov Regul Sci. 2019. PMID: 30360656

8

How the FDA Ensures High-Quality Generic Drugs.

Uhl K, Peters JR. Uhl K, et al. Am Fam Physician. 2018 Jun 1;97(11):696-697. Am Fam Physician. 2018. PMID: 30215932 Free article. No abstract available.

9

Development of performance matrix for generic product equivalence of acyclovir topical creams.

Krishnaiah YS, Xu X, Rahman Z, Yang Y, Katragadda U, Lionberger R, Peters JR, Uhl K, Khan MA. Krishnaiah YS, et al. Int J Pharm. 2014 Nov 20;475(1-2):110-22. doi: 10.1016/j.ijpharm.2014.07.034. Epub 2014 Jul 30. Int J Pharm. 2014. PMID: 25089511

10

Burden of changes in generic pill appearance.

Uhl K, Peters JR. Uhl K, et al. Ann Intern Med. 2014 Dec 2;161(11):839. doi: 10.7326/L14-5028. Ann Intern Med. 2014. PMID: 25437414 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,145 results

Search Page

Filters